Intuitive Surgical (NASDAQ:ISRG) Upgraded at Erste Group Bank

Erste Group Bank upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a hold rating to a buy rating in a research note issued to investors on Wednesday, Marketbeat reports.

Other equities analysts have also recently issued research reports about the company. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Sunday, September 20th. Robert W. Baird cut their target price on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. Oppenheimer raised shares of Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 target price on the stock in a report on Wednesday, August 12th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Finally, TD Cowen reiterated a “buy” rating and issued a $485.00 price target on shares of Intuitive Surgical in a research note on Monday. Twenty-three equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Price Performance

ISRG opened at $452.29 on Wednesday. Intuitive Surgical has a 12 month low of $328.57 and a 12 month high of $603.88. The stock has a market capitalization of $156.78 billion, a price-to-earnings ratio of 49.76, a PEG ratio of 3.31 and a beta of 1.46. The business has a fifty day moving average price of $395.50 and a 200 day moving average price of $409.13.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.40 EPS. On average, research analysts anticipate that Intuitive Surgical will post 8.87 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 400 shares of Intuitive Surgical stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the sale, the director directly owned 251 shares of the company’s stock, valued at $95,129. The trade was a 61.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock valued at $4,891,989 over the last ninety days. Company insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Trueblood Wealth Management LLC lifted its stake in Intuitive Surgical by 1.7% during the third quarter. Trueblood Wealth Management LLC now owns 1,551 shares of the medical equipment provider’s stock worth $631,000 after purchasing an additional 26 shares during the last quarter. Norris Perne & French LLP MI boosted its holdings in Intuitive Surgical by 118.2% in the third quarter. Norris Perne & French LLP MI now owns 2,082 shares of the medical equipment provider’s stock valued at $847,000 after purchasing an additional 1,128 shares in the last quarter. Signaturefd LLC boosted its holdings in Intuitive Surgical by 8.3% in the third quarter. Signaturefd LLC now owns 7,582 shares of the medical equipment provider’s stock valued at $3,083,000 after purchasing an additional 582 shares in the last quarter. Corecam Pte. Ltd. boosted its holdings in Intuitive Surgical by 23.2% in the third quarter. Corecam Pte. Ltd. now owns 690 shares of the medical equipment provider’s stock valued at $281,000 after purchasing an additional 130 shares in the last quarter. Finally, McGuire Investment Group LLC increased its stake in Intuitive Surgical by 0.8% in the third quarter. McGuire Investment Group LLC now owns 29,119 shares of the medical equipment provider’s stock valued at $11,841,000 after purchasing an additional 224 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.